Key Takeaways
- Tirzepatide is the active pharmaceutical ingredient in Mounjaro and Zepbound—the first once-weekly dual GIP and GLP-1 receptor agonist.
- In Phase 3 SURMOUNT-1 and SURMOUNT-4 trials, tirzepatide delivered 22.5% to 25.3% mean body-weight reductions when combined with nutrition and exercise.
- Dosing always starts at 2.5 mg once weekly for 4 weeks and escalates in 2.5 mg steps up to a maximum of 15 mg based on individual response and tolerability.
- Compared head-to-head against single-receptor semaglutide (up to ~17% weight loss in STEP trials), dual GIP/GLP-1 signaling drives deeper average fat loss with a similar GI profile.
How Dual GIP & GLP-1 Signaling Drives Weight Loss
Pronounced ter-ZEP-uh-tide, tirzepatide is a single synthetic peptide engineered to activate two natural gut-hormone receptors simultaneously: GLP-1 and GIP. Together, this dual action:
- Quiets central hunger and reward cravings in the brain so you feel satisfied with smaller portions.
- Slows gastric emptying so meals keep you comfortably full for hours.
- Enhances insulin sensitivity and metabolic flexibility in adipose and muscle tissue.
Standard 4-Week Dose Escalation Schedule
| Treatment Phase | Weekly Strength | Clinical Notes |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Mandatory starter dose for GI acclimation |
| Weeks 5–8+ | 5 mg | First therapeutic maintenance tier—stay here if losing steadily |
| Weeks 9–12+ | 7.5 mg | Optional step-up after ≥4 weeks on 5 mg |
| Weeks 13–16+ | 10 mg | Established maintenance tier |
| Weeks 17–20+ | 12.5 mg → 15 mg | Higher tiers if needed; maximum weekly dose is 15 mg |
Tirzepatide vs. Semaglutide at a Glance
Both tirzepatide and semaglutide are once-weekly subcutaneous injections sharing similar temporary GI adjustment effects (mild nausea, diarrhea, constipation, or reflux). While semaglutide activates GLP-1 alone (achieving ~15%–17% average weight loss in trials), tirzepatide’s added GIP activity yielded up to 22.5% at 72 weeks in SURMOUNT-1. Explore personalized GLP-1 and GIP/GLP-1 options at Amble Weight Loss.
Medical Editorial Review: Reviewed by the Amble Metabolic Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.
Related Clinical Guides
Women's Health & Hormones · 5 min readWhat Happened to Ovestin Cream? Estriol 0.1% Rebrand & Vaginal Estrogen AlternativesTold Ovestin vaginal cream is discontinued or out of stock? Learn why it was simply rebranded as generic Estriol 0.1% (1 mg/g) cream—and compare gels, pessaries, and 90-day estradiol rings.Women's Health & Hormones · 6 min readWhy Do I Keep Getting Cystitis & UTIs in My 40s? The Perimenopause LinkRecurrent bladder infections in your 40s and 50s often trace back to declining perimenopausal estrogen. Learn how localized vaginal estrogen restores protective flora and cuts repeat UTIs.Skincare & Dermatology · 6 min readWhat Is Post-Inflammatory Hyperpigmentation (PIH)? Causes, Skin Tones & PreventionLingering flat brown, tan, or dark marks long after a breakout heals? Learn how post-inflammatory hyperpigmentation differs from true acne scarring and post-inflammatory erythema.
Medical weight losstailored to your biology
Clinician-guided GLP-1 and dual-hormone programs delivered discreetly.